We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-13.1%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$5B
AUM Growth
-$909M
Cap. Flow
-$36.2M
Cap. Flow %
-0.72%
Top 10 Hldgs %
18.91%
Holding
2,646
New
66
Increased
797
Reduced
791
Closed
99

Sector Composition

Rank Sector Weight
1 Technology 16.57%
2 Financials 13.9%
3 Healthcare 13.55%
4 Consumer Discretionary 10%
5 Industrials 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDLI
2076
DELISTED
PDL BioPharma, Inc.
PDLI
$137K ﹤0.01%
47,074
JCAP
2077
DELISTED
Jernigan Capital, Inc.
JCAP
$136K ﹤0.01%
6,873
+862
+14% +$17.5K
HWKN icon
2078
Hawkins
HWKN
$2.67B
$135K ﹤0.01%
6,610
KURA icon
2079
Kura Oncology
KURA
$896M
$135K ﹤0.01%
9,638
PCSB
2080
DELISTED
PCSB Financial Corporation
PCSB
$135K ﹤0.01%
6,909
RYTM icon
2081
Rhythm Pharmaceuticals
RYTM
$7.99B
$135K ﹤0.01%
5,020
+647
+15% +$17.9K
ANH
2082
DELISTED
Anworth Mortgage Asset Corporation
ANH
$135K ﹤0.01%
33,389
PFSI icon
2083
PennyMac Financial
PFSI
$4.13B
$135K ﹤0.01%
6,344
NIHD
2084
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$135K ﹤0.01%
30,542
LASR icon
2085
nLIGHT
LASR
$2.9B
$134K ﹤0.01%
+7,555
New +$143K
CDR
2086
DELISTED
Cedar Realty Trust, Inc
CDR
$134K ﹤0.01%
6,480
-25
-0.4% -$606
PRTA icon
2087
Prothena Corp
PRTA
$466M
$134K ﹤0.01%
13,019
NRC icon
2088
NRC Health Common Stock
NRC
$471M
$134K ﹤0.01%
3,511
COWN
2089
DELISTED
Cowen Inc. Class A Common Stock
COWN
$134K ﹤0.01%
10,014
+969
+11% +$14.8K
TBBK icon
2090
The Bancorp
TBBK
$2.82B
$133K ﹤0.01%
16,734
LMAT icon
2091
LeMaitre Vascular
LMAT
$1.87B
$133K ﹤0.01%
5,629
XPRO icon
2092
Expro Ltd
XPRO
$2.1B
$133K ﹤0.01%
4,244
EIGI
2093
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$133K ﹤0.01%
19,984
BBSI icon
2094
Barrett Business Services
BBSI
$800M
$133K ﹤0.01%
9,284
VCYT icon
2095
Veracyte
VCYT
$3.42B
$133K ﹤0.01%
10,544
PETQ
2096
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$133K ﹤0.01%
5,647
+1,734
+44% +$53.5K
NVEC icon
2097
NVE Corp
NVEC
$563M
$132K ﹤0.01%
1,513
NSTG
2098
DELISTED
NanoString Technologies, Inc.
NSTG
$132K ﹤0.01%
8,893
+969
+12% +$15.4K
WRD
2099
DELISTED
WildHorse Resource Development
WRD
$132K ﹤0.01%
9,341
CONN
2100
DELISTED
Conn's Inc.
CONN
$131K ﹤0.01%
6,959

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2018 Portfolio in Review

As of Q4 2018, Metropolitan Life Insurance Company (MetLife) held 2,646 positions worth $5B, down 15% from $5.91B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2018 filing shows 66 new, 797 increased, 791 reduced and 99 closed positions. Its largest new stake was Equitrans Midstream Corporation Common Stock: 58,446 shares worth $1.17M. The largest sale was Aetna Inc, an estimated $10.8M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2018 buy was Equitrans Midstream Corporation Common Stock: 58,446 shares worth $1.17M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $61M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2018 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $10.4M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Aetna Inc in Q4 2018, selling an estimated $10.8M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 19% of its $5B portfolio in Q4 2018.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 99 in Q4 2018.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 15% quarter-over-quarter to $5B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2018, filed 14 Feb 2019.